These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31118475)

  • 1. AAV-encoded Ca
    Yu H; Shin SM; Xiang H; Chao D; Cai Y; Xu H; Khanna R; Pan B; Hogan QH
    Gene Ther; 2019 Aug; 26(7-8):308-323. PubMed ID: 31118475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion.
    Fischer G; Pan B; Vilceanu D; Hogan QH; Yu H
    Gene Ther; 2014 Jan; 21(1):44-51. PubMed ID: 24152582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
    François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
    Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.
    Piekarz AD; Due MR; Khanna M; Wang B; Ripsch MS; Wang R; Meroueh SO; Vasko MR; White FA; Khanna R
    Mol Pain; 2012 Jul; 8():54. PubMed ID: 22828369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary sensory neuron-specific interference of TRPV1 signaling by AAV-encoded TRPV1 peptide aptamer attenuates neuropathic pain.
    Xiang H; Liu Z; Wang F; Xu H; Roberts C; Fischer G; Stucky C; Caron D; Pan B; Hogan Q; Yu H
    Mol Pain; 2017; 13():1744806917717040. PubMed ID: 28604222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
    Xie JY; Chew LA; Yang X; Wang Y; Qu C; Wang Y; Federici LM; Fitz SD; Ripsch MS; Due MR; Moutal A; Khanna M; White FA; Vanderah TW; Johnson PL; Porreca F; Khanna R
    Pain; 2016 Sep; 157(9):2124-2140. PubMed ID: 27537210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
    Feldman P; Khanna R
    Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of N-type voltage-gated calcium channels (Cav2.2) and transmitter release by collapsin response mediator protein-2 (CRMP-2) in sensory neurons.
    Chi XX; Schmutzler BS; Brittain JM; Wang Y; Hingtgen CM; Nicol GD; Khanna R
    J Cell Sci; 2009 Dec; 122(Pt 23):4351-62. PubMed ID: 19903690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.
    Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R
    Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats.
    Yu H; Fischer G; Ferhatovic L; Fan F; Light AR; Weihrauch D; Sapunar D; Nakai H; Park F; Hogan QH
    PLoS One; 2013; 8(4):e61266. PubMed ID: 23613824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of N-type calcium channels in the soma of uninjured dorsal root ganglion neurons contributes to neuropathic pain by increasing neuronal excitability following peripheral nerve injury.
    Yang J; Xie MX; Hu L; Wang XF; Mai JZ; Li YY; Wu N; Zhang C; Li J; Pang RP; Liu XG
    Brain Behav Immun; 2018 Jul; 71():52-65. PubMed ID: 29709527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective block of sensory neuronal T-type/Cav3.2 activity mitigates neuropathic pain behavior in a rat model of osteoarthritis pain.
    Itson-Zoske B; Shin SM; Xu H; Qiu C; Fan F; Hogan QH; Yu H
    Arthritis Res Ther; 2022 Jul; 24(1):168. PubMed ID: 35842727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripherally targeted analgesia via AAV-mediated sensory neuron-specific inhibition of multiple pronociceptive sodium channels.
    Shin SM; Itson-Zoske B; Fan F; Xiao Y; Qiu C; Cummins TR; Hogan QH; Yu H
    J Clin Invest; 2024 May; 134(13):. PubMed ID: 38722683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons.
    Cai S; Shan Z; Zhang Z; Moutal A; Khanna R
    Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.
    Wilson SM; Schmutzler BS; Brittain JM; Dustrude ET; Ripsch MS; Pellman JJ; Yeum TS; Hurley JH; Hingtgen CM; White FA; Khanna R
    J Biol Chem; 2012 Oct; 287(42):35065-35077. PubMed ID: 22891239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.
    Wilson SM; Brittain JM; Piekarz AD; Ballard CJ; Ripsch MS; Cummins TR; Hurley JH; Khanna M; Hammes NM; Samuels BC; White FA; Khanna R
    Channels (Austin); 2011; 5(5):449-56. PubMed ID: 21829088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptidomimetic modulator of the Ca
    Gomez K; Santiago U; Nelson TS; Allen HN; Calderon-Rivera A; Hestehave S; Rodríguez Palma EJ; Zhou Y; Duran P; Loya-Lopez S; Zhu E; Kumar U; Shields R; Koseli E; McKiver B; Giuvelis D; Zuo W; Inyang KE; Dorame A; Chefdeville A; Ran D; Perez-Miller S; Lu Y; Liu X; Handoko ; Arora PS; Patek M; Moutal A; Khanna M; Hu H; Laumet G; King T; Wang J; Damaj MI; Korczeniewska OA; Camacho CJ; Khanna R
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2305215120. PubMed ID: 37972067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal Fbxo3-Dependent Fbxl2 Ubiquitination of Active Zone Protein RIM1α Mediates Neuropathic Allodynia through CaV2.2 Activation.
    Lai CY; Ho YC; Hsieh MC; Wang HH; Cheng JK; Chau YP; Peng HY
    J Neurosci; 2016 Sep; 36(37):9722-38. PubMed ID: 27629721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.
    Buchta WC; Moutal A; Hines B; Garcia-Keller C; Smith ACW; Kalivas P; Khanna R; Riegel AC
    Mol Neurobiol; 2020 Jan; 57(1):346-357. PubMed ID: 31359322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex.
    Brittain JM; Duarte DB; Wilson SM; Zhu W; Ballard C; Johnson PL; Liu N; Xiong W; Ripsch MS; Wang Y; Fehrenbacher JC; Fitz SD; Khanna M; Park CK; Schmutzler BS; Cheon BM; Due MR; Brustovetsky T; Ashpole NM; Hudmon A; Meroueh SO; Hingtgen CM; Brustovetsky N; Ji RR; Hurley JH; Jin X; Shekhar A; Xu XM; Oxford GS; Vasko MR; White FA; Khanna R
    Nat Med; 2011 Jun; 17(7):822-9. PubMed ID: 21642979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.